Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Extract, edited.]
H Kelly (
)<SUP>1</SUP><SUP>,2</SUP>, I Steffens<SUP>3</SUP>
Citation style for this article: Kelly H, Steffens I. Complexities in assessing the effectiveness of inactivated influenza vaccines. Euro Surveill. 2013;18(7)
ii=20403. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20403 - Date of submission: 12 February 2013 <HR>
For many years it has been generally accepted that well-matched vaccines are the most effective single measure to protect people who are predisposed to a more severe outcome following infection with the influenza virus [1]. This group includes those aged at least 65 years, pregnant women and those who suffer from specific chronic conditions and/or are immunocompromised. (?)
- ------
Eurosurveillance, Volume 18, Issue 7, 14 February 2013
Editorials
Complexities in assessing the effectiveness of inactivated influenza vaccines
Editorials
Complexities in assessing the effectiveness of inactivated influenza vaccines
H Kelly (
- Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
- National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia
- European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Citation style for this article: Kelly H, Steffens I. Complexities in assessing the effectiveness of inactivated influenza vaccines. Euro Surveill. 2013;18(7)
ii=20403. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20403 - Date of submission: 12 February 2013 <HR>For many years it has been generally accepted that well-matched vaccines are the most effective single measure to protect people who are predisposed to a more severe outcome following infection with the influenza virus [1]. This group includes those aged at least 65 years, pregnant women and those who suffer from specific chronic conditions and/or are immunocompromised. (?)